Efficacy of a Novel Cellular, Acellular, Matrix-like Product (CAMP) Plus Standard of Care Versus Standard of Care Alone in the Management of Post-Mohs Micrographic Surgery Defects.

Conditions

• Cutaneous Malignancy
• Mohs Micrographic Surgery
• Mohs Surgical Defect

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Control Dressing + Standard of Care — OTHER
  Beginning at the screening visit, participants will receive weekly treatment with standard of care (cleaning, debridement, ulcer moisture balance, and offloading) until ulcer closure, or a maximum of 6 weeks, whichever occurs first.
• CAMP + Standard of Care — OTHER
  Participants will receive weekly applications of Membrane Wrap-Lite and Standard of Care until ulcer closure, or a maximum of 6 weeks, whichever occurs first.

Study Details

A multicenter, prospective, randomized controlled clinical trial assessing the efficacy of a novel cellular, acellular, matrix-like product (CAMP) plus standard of care versus standard of care alone in the management of post-mohs micrographic surgery defects.

Key Dates

First listed

Jul 10, 2026

Start date

Sep 18, 2026

Status verified

Sep 2026

Primary completion

Jul 1, 2028

Completion

Jul 1, 2028

Study Design

Enrollment

160 participants (estimated)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Arms

• Active Comparator: Control Dressing + Standard of Care
  Standard of care will be cleaning, debridement, ulcer moisture balance, control dressing and offloading.
• Other: CAMP + Standard of Care
  Membrane Wrap-Lite is a human amniotic membrane tissue allograft derived from human placental tissue.

Primary Outcome Measure

Complete Wound Closure [ Time Frame: 1-6 Weeks ]

Central Contacts

• Bennett Sarver
  1-833-865-6300
  [email protected]

Locations (1)

Find similar trials in Tulsa, OK

Related Studies

• Topical 0.5% Timolol Solution for Healing Lower Extremity Wounds
  PHASE1 · Recruiting · Icahn School of Medicine at Mount Sinai · New York, New York
• Efficacy and Safety of Topical Timolol in Secondary Intention Surgical Wounds Healing
  PHASE2 · Not Yet Recruiting · University of California, Davis · Sacramento, California
• Suzetrigine vs Norco-postoperative Mohs Pain
  PHASE4 · Enrolling By Invitation · Baylor Research Institute · Dallas, Texas
• Local Anesthetic Clinical Trial
  PHASE4 · Enrolling By Invitation · Baylor Research Institute · Dallas, Texas